PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
COMPANY
PROFILE

News by Category |News by Country| News by US Region |Recent News| Add PR.com Press Releases to Your Website
Eden Spine, LLC
 

Company Overview

Products & Services

Contact Info & Offices

Press Releases

Image Gallery

Eden Spine, LLC

Press Release

Share      Blog

Receive press releases from Eden Spine, LLC: By Email PDF Version RSS Feeds:
Eden Spine Receives New Patent for Its Posterior Dynamic Stabilization System, the PERFX-2

Eden Spine Receives New Patent for Its Posterior Dynamic Stabilization System, the PERFX-2
Lake Mary, FL, September 08, 2010 --(PR.com)-- Eden Spine (www.EdenSpine.com), a Florida based Medical Devices organization focused on developing the latest generation of spinal technologies, has been granted a U.S. patent from the United States Patent and Trademark Office (USPTO) and from the European Patent Office for the PERFX-2™, a Posterior Dynamic Stabilization system designed to remove pain without necessarily removing motion.

The PERFX-2™ is a pedicle screw based dynamic stabilization system, CE Marked and currently distributed internationally. According to Mourad Ben Mokhtar, head of Eden Spine’s Research & Development efforts, “The PERFX-2™ is the latest generation Dynamic Rod technology. It was designed to achieve stabilization of the diseased spinal segment while closely replicating its natural function, for better long term results.”

“Fusion has been the standard of care for debilitating back pain for over 3 decades,” said Guillaume Viallaneix, CEO. He added, “With an estimated 35% of fusion cases producing adjacent disc disease, it is clear that new, friendlier, motion preserving treatment options, that better replicate the natural movement of the spine, are in the best interest of both the patient and society. The PERFX-2™ is a step in that direction.”

"This Patent provides further validation of our innovative approach to spinal research and highlights the potential for a significant advance in the treatment of a wide array of spinal indications,” added Guillaume Viallaneix, CEO. “With this patent, along with the rest of our IP portfolio and our extensive R&D efforts, we are in a strong position to move forward with our development plans in 2011 and beyond.”

###
Contact Information
Eden Spine, LLC
Guillaume Viallaneix
407-792-2279
Contact
www.EdenSpine.com

Click here to view the company profile of Eden Spine, LLC
Click here to view the list of recent Press Releases from Eden Spine, LLC
Promote Your Business